Neuphoria Therapeutics
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $15,000 | $662 | $0 | $0 |
Gross Profit | 14,835 | 662 | -165 | |
EBITDA | 11,346 | -3,231 | -771 | |
EBIT | 11,180 | -3,397 | -936 | |
Net Income | 11,262 | -1,943 | -805 | -2,687 |
Net Change In Cash | 15,000 | 662 | 0 | 0 |
Free Cash Flow | 11,218 | -3,358 | -4,433 | -3,010 |
Cash | 17,045 | 4,345 | 8,082 | 12,608 |
Basic Shares | 234,011 | 234,011 | 234,012 | 2,384,539 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $6,055 | $928 |
Gross Profit | -9,943 | -4,834 | ||
EBITDA | -17,134 | -20,897 | -14,318 | -4,514 |
EBIT | -17,797 | -21,560 | -15,081 | -5,792 |
Net Income | -15,492 | -21,381 | -14,968 | -6,534 |
Net Change In Cash | 0 | 0 | 6,055 | 928 |
Free Cash Flow | -14,681 | -14,637 | -14,966 | -5,665 |
Cash | 12,608 | 12,103 | 23,089 | 21,412 |
Basic Shares | 149,800 | 122,394 | 112,779 | 64,995 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | $6.55 |
2024-12-31 | -$1.23 |
2024-09-30 | -$0.003 |
2024-03-31 | -$33.98 |
